Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemias”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT03013998
What this trial is testing

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

Who this might be right for
Previously Untreated Relapsed Refractory Acute Myeloid Leukemia
Beat AML, LLC 3,000
Not applicableStudy completedNCT01233921
What this trial is testing

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more
Martin, Paul 6
Not applicableLooking for participantsNCT04777916
What this trial is testing

Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
Acute Leukemia French Association 5,000
Not applicableLooking for participantsNCT06874257
What this trial is testing

Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade

Who this might be right for
AML (Acute Myelogenous Leukemia)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 20
Not applicableStudy completedNCT00339664
What this trial is testing

Analyses of Human Samples Collected in Clinical Trials

Who this might be right for
Leukemia, MyeloidNeoplasm MetastasisLeukemia, Lymphoid+1 more
National Cancer Institute (NCI) 2,579
Large-scale testing (Phase 3)Looking for participantsNCT07232134
What this trial is testing

The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia

Who this might be right for
AML (Acute Myelogenous Leukemia)Down Syndrome (DS)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 100
Early research (Phase 1)Ended earlyNCT03126864
What this trial is testing

Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia

Who this might be right for
Hematopoietic/Lymphoid CancerAcute Myeloid Leukemia
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00762632
What this trial is testing

Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Technical University of Munich 40
Testing effectiveness (Phase 2)Looking for participantsNCT06514534
What this trial is testing

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

Who this might be right for
Chronic Myeloid Leukemia (CML)
Novartis Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT01098084
What this trial is testing

Decitabine in Patients With Chronic Myelomonocytic Leukemia (CMML)

Who this might be right for
Chronic Myelomonocytic Leukemia
Groupe Francophone des Myelodysplasies 41
Large-scale testing (Phase 3)Study completedNCT01460693
What this trial is testing

Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia

Who this might be right for
Myeloid Leukemia, Chronic, Chronic Phase
Newcastle University 814
Testing effectiveness (Phase 2)Study completedNCT01700673
What this trial is testing

Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Not applicableNot Yet RecruitingNCT06022341
What this trial is testing

MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic Strategies

Who this might be right for
Myeloproliferative NeoplasmSecondary Leukemia
University Hospital, Angers 120
Testing effectiveness (Phase 2)Study completedNCT00001873
What this trial is testing

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more
National Heart, Lung, and Blood Institute (NHLBI) 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT04232241
What this trial is testing

Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid Leukemia in RemissionAcute Lymphoblastic Leukemia in RemissionMyelodysplastic Syndromes
Universitätsklinikum Hamburg-Eppendorf 167
Large-scale testing (Phase 3)Ended earlyNCT01650805
What this trial is testing

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Who this might be right for
Chronic Myeloid Leukemia
Ariad Pharmaceuticals 307
Not applicableStudy completedNCT01288222
What this trial is testing

Selecting a Favorable KIR Donor in Unrelated HCT for AML

Who this might be right for
Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 506
Early research (Phase 1)Study completedNCT02367456
What this trial is testing

A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Pfizer 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT04231851
What this trial is testing

CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia

Who this might be right for
Acute Myelogenous Leukemia (AML) Due to TherapyAcute Myeloid Leukemia With Myelodysplasia-Related Changes
University of California, Irvine 30
Testing effectiveness (Phase 2)Looking for participantsNCT06566742
What this trial is testing

Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaClonal Cytopenia of Undetermined Significance
M.D. Anderson Cancer Center 15
Next Page